Abstract
This article describes over 20 years of research on antagonists of the cell adhesion molecule, N-cadherin. Four types of antagonists are discussed: synthetic linear peptides, synthetic cyclic peptides, non-peptidyl peptidomimetics of the disulfide linked cyclic peptide N-Ac-CHAVC-NH2 and monoclonal antibodies directed against the N-cadherin ectodomain. The biological activities of these antagonists are also discussed. In particular, the ability of N-cadherin antagonists to act as anti-cancer drugs is considered.
Similar content being viewed by others
References
Augustine CK, Yoshimoto Y, Gupt M, Zipfel PA, Selim MA, Febbo P, Pendergast AM, Peters WP, Tyler DS (2008) Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment. Cancer Res 68:3777–3784
Baluk P, Hashimyza H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15:102–111
Beasley GM, McMahon N, Sanders G, Augustine CK, Selim MA, Peterson B, Norris R, Peters WP, Ross MI, Tyler DS (2009) A Phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. Cancer 115:4766–4774
Blaschuk OW, Devemy E (2009) Cadherins as novel targets for anti-cancer therapy. Eur J Pharmacol 625:195–198
Blaschuk OW, Gour B (2000) Compounds and methods for modulating cell adhesion. United States Patent Number 6,031,072
Blaschuk OW, Sullivan R, David S, Pouliot Y (1990) Identification of a cadherin cell adhesion recognition sequence. Develop Biol 139:227–229
Blaschuk OW, Gour BJ, Farookhi R, Anmar A (2003) Compounds and methods for modulating endothelial cell adhesion. United States Patent Number 6,610,821
Bryan RT, Tselepis T (2010) Cadherin switching and bladder cancer. J Urol 184:423–431
Devemy E, Blaschuk OW (2008) Identification of a novel N-cadherin antagonist. Peptides 29:1853–1861
Doherty P, Rowett LH, Moore SE, Mann SE, Walsh FS (1991) Neurite outgrowth in response to transfected N-CAM and N-cadherin reveals fundamental differences in neuronal responsiveness to CAMs. Neuron 6:247–258
Erez N, Zamir E, Gour BJ, Blaschuk OW, Geiger B (2004) Induction of apoptosis in cultured endothelial cells by a cadherin antagonist peptide: involvement of fibroblast growth factor receptor-mediated signalling. Exp Cell Res 294:366–378
Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273–286
Franke WW (2009) Discovering the molecular components of intercellular junctions—a historical view. Cold Spring Harb Perspect Biol 1:a003061
Gaengel K, Genové G, Armulik A, Betsholtz C (2009) Endothelial–mural cell signalling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29:630–638
Gerhardt H, Wolburg H, Redies C (2000) N-cadherin mediates pericyte–endothelial interaction during brain angiogenesis in the chicken. Dev Dyn 218:472–479
Gour BJ, Blaschuk OW, Ali A, Ni F, Chen Z, Michaud SD, Wang S, Hu Z (2007) Peptidomimetic modulators of cell adhesion. United States Patent Number 7,268,115
Hansen SM, Berezin V, Bock E (2008) Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-cadherin. Cell Mol Life Sci 65:3809–3821
Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779–790
Hazan RB, Qiao R, Keren R, Badano I, Suyama K (2004) Cadherin switch in tumor progression. Ann N Y Acad Sci 1014:155–163
Hulpiau P, van Roy F (2008) Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol 41:349–369
Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel VV, Molkentin JD, Radice GL (2005) Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 96:346–354
Lyon CA, Koutsouki E, Aguilera CM, Blaschuk OW, George SJ (2010) Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis. J Vasc Surg 52:1301–1309
Mege RM, Goudou D, Diaz C, Nicolet M, Garcia L, Geraud G, Rieger F (1992) N-cadherin and N-CAM in myoblast fusion: compared localisation and effect of blockade by peptides and antibodies. J Cell Sci 103:897–906
Naumov GN, Folkman J, Straume O, Akslen LA (2008) Tumor–vascular interactions and tumor dormancy. APMIS 116:569–585
Paik J-H, Skoura A, Chae S-S, Cowan AE, Han DK, Proia RL, Hla T (2004) Shingosine1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev 18:2392–2403
Perotti A, Sessa C, Mancuso A, Noberasco C, Cresta S, Locatelli A, Carcangiu ML, Passera K, Braghetti A, Scaramuzza D, Zanaboni F, Fasolo A, Capri G, Miani M, Peters WP, Gianni L (2009) Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours. Ann Oncol 20:741–745
Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran C, Wistuba II (2009) Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol 22:668–678
Salomon D, Ayalon O, Patel R, King P, Hynes RO, Geiger B (1992) Extrajunctional distribution of N-cadherin in cultured human endothelial cells. J Cell Sci 102:7–17
Sanchez-Heras E, Howell FV, Williams G, Doherty P (2006) The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule. J Biol Chem 281:35208–35216
Shapiro L, Weis WI (2009) Structure and biochemistry of cadherins and catenins. Cold Spring Harb Perspect Biol 1:a003053
Shintani Y, Fukumoto Y, Chaika N, Grandgenett PM, Hollingsworth MA, Wheelock MJ, Johnson KR (2008) ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. Int J Cancer 122:71–77
Takeichi M (1988) The cadherins: Cell–cell adhesion molecules controlling animal morphogenesis. Development 102:639–655
Tamura K, Shan W, Hendrickson W, Colman D, Shapiro L (1998) Structure–function analysis of cell adhesion by neural (N-) cadherin. Neuron 20:1153–1163
Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE (2010) Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance. Nature Med 16:1414–1420
Tomita K, van Bokhoven A, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, Schalken JA (2000) Cadherin switching in human prostate cancer progression. Cancer Res 60:3650–3654
Troyanovsky RB, Laur O, Troyanovsky SM (2007) Stable and unstable cadherin dimers: mechanisms of formation and roles in cell adhesion. Mol Biol Cell 18:4343–4352
Vendome J, Posy S, Jin X, Bahna F, Ahlsen G, Shapiro L, Honig B (2011) Molecular design principles underlying β-strand swapping in the adhesive dimerization of cadherins. Nat Struc Mol Biol 18:693–700
Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR (2008) Cadherin switching. J Cell Sci 121:727–735
Wilby MJ, Muir EM, Fok-Seang J, Gour BJ, Blaschuk OW, Fawcett J (1999) N-cadherin inhibits Schwann cell migration on astrocytes. Mol Cell Neurosci 14:66–84
Acknowledgements
I thank Tracey Rowlands for helpful comments concerning the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blaschuk, O.W. Discovery and development of N-cadherin antagonists. Cell Tissue Res 348, 309–313 (2012). https://doi.org/10.1007/s00441-011-1320-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-011-1320-5